Ranbaxy CEO: Pfizer Deal Won’t Attract FTC
Make a commentBy Ed Silverman // June 19th, 2008 // 9:33 am
• Pharma Blog » Archives
Federal Trade Commission
FTC Derides Pay-To-Delay Deals With Generics
Make a commentBy Ed Silverman // May 21st, 2008 // 5:16 pm
AstraZeneca And Ranbaxy Settle Nexium Dispute
Make a commentBy Ed Silverman // April 15th, 2008 // 7:50 am
FTC Commish Vows To Fight ‘Pay-For-Delay’ Deals
3 CommentsBy Ed Silverman // February 25th, 2008 // 8:02 am
FTC Sues Cephalon For Paying Off Generic Rivals
3 CommentsBy Ed Silverman // February 13th, 2008 // 5:45 pm
Patent Settlements: Who Really Wins?
Make a commentBy Ed Silverman // February 23rd, 2007 // 7:05 am
Gilead Unfairly Controls AIDS Ingredients
1 CommentBy Ed Silverman // February 15th, 2007 // 8:21 am